Las Vegas, NV -- (SBWIRE) -- 01/06/2014 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Amarin Corporation plc (ADR) (NASDAQ:AMRN), JPMorgan Chase & Co. (NYSE:JPM), Generex Biotechnology Corporation (OTCMKTS:GNBT), EXCO Resources Inc (NYSE:XCO).
Amarin Corporation plc (ADR) (NASDAQ:AMRN) ended its recent business day with the advanced of 1.53% and closed at the price of $1.99 after opening at $1.99. The stock traded during its last trading session with the total volume of 4.44 million shares, as compared to its average volume of 5.41 million shares. Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and therapeutic benefits of polyunsaturated fatty acids.
Will AMRN Continue To Move Higher? Find out via this report
JPMorgan Chase & Co. (NYSE:JPM) remained among the day bullish 0.77% and traded with volume of 14.22 million shares in the last session, as compared to average volume of 15.69 million shares. In comparison with 52 week range of $44.44 - $58.95, it faced lowest price of $58.21 during the last trading session whereas its day highest price was $58.95. The company’s total market capitalization is $220.51 billion, along with 3.76 billion shares outstanding. JPMorgan Chase & Co., a financial holding company, provides various financial services worldwide.
Will JPM Continue To Move Higher? Find out via this report
Generex Biotechnology Corporation (OTCMKTS:GNBT) showed 2.34 million shares in volume during the last trading session, while the average trading volume remained 1.89 million shares. The stock kicked off its trading session at $0.03 and closed at $0.0320 after rallied 6.67%. Generex Biotechnology Corporation, a development stage company, is engaged in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases.
Why Should Investors Buy GNBT After The Recent Gain? Just Go Here and Find Out
EXCO Resources Inc (NYSE:XCO) stock traded during its last trading session with the total traded volume of 4.21 million shares versus its average volume of 4.34 million shares. The company opened its trade at the price of $5.24 and its closing price was $5.14 after fell -1.53% for the day. EXCO Resources, Inc., an independent oil and natural gas company, engages in the acquisition, exploration, exploitation, development and production of onshore U.S.
Has XCO Found The Bottom and Ready To Move Up? Find Out Here
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)